Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Glia in FTLD-GRN: from supporting cast to leading role
Emile S. Pinarbasi, Sami J. Barmada
Emile S. Pinarbasi, Sami J. Barmada
Published March 15, 2023
Citation Information: J Clin Invest. 2023;133(6):e168215. https://doi.org/10.1172/JCI168215.
View: Text | PDF
Commentary

Glia in FTLD-GRN: from supporting cast to leading role

  • Text
  • PDF
Abstract

A subset of the neurodegenerative disease frontotemporal lobar degeneration (FTLD) is caused by mutations in the progranulin (GRN) gene. In this issue of the JCI, Marsan and colleagues demonstrate disease-specific transcriptional profiles in multiple glial cell lineages — astrocytes, microglia, and oligodendroglia — that are highly conserved between patients with FTLD-GRN and the widely used Grn–/– mouse model. Additionally, the authors show that Grn–/– astrocytes fail to adequately maintain synapses in both mouse and human models. This study presents a compelling argument for a central role for glia in neurodegeneration and creates a rich resource for extending mechanistic insight into pathophysiology, identifying potential biomarkers, and developing therapeutic approaches.

Authors

Emile S. Pinarbasi, Sami J. Barmada

×

Figure 1

Noncell autonomous mechanisms contribute to FTLD-GRN.

Options: View larger image (or click on image) Download as PowerPoint
Noncell autonomous mechanisms contribute to FTLD-GRN.
Multiple cell and ...
Multiple cell and tissue types factor into neurodegeneration in FTLD-GRN. Data from Marsan et al. (10) indicate that GRN deficiency induces downstream changes in all four cell types of the brain. Atrophy, gliosis, neuronal loss, and TDP-43 poteinopathy are prominent in gray matter, evident at both the subcellular and transcriptional levels. Microglia increase synaptic pruning and display a disease-specific transcriptional profile, including the upregulation of C1q. Astrocytes fail to maintain synapses, resulting in disrupted synapse number and morphology. The downregulation of synaptic genes in neurons include TDP-43 target RNAs associated with TDP-43 nuclear exclusion and cytoplasmic deposition. Although TDP-43 proteinopathy is mild and variable in white matter, other pathological changes, including gliosis, myelin loss, and myelin debris within microglia, are more common. DEGs are highly enriched in oligodendroglia, suggesting that these cells are substantially impacted in FTLD-GRN.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts